Showing results (1-10 of 331) with videos related to
Sort By:
Pageof 34
Toxins|January 20, 2023
OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain IntensityDilara Onan, Enrico Bentivegna, Paolo MartellettiNeurology and Therapy|February 4, 2023
Unmet Needs in Preventive Treatment of MigraineEnrico Bentivegna, Dilara Onan, Paolo MartellettiSN Comprehensive Clinical Medicine|December 2, 2020
Headache as a Prognostic Factor for COVID-19. Time to Re-evaluatePaolo Martelletti, Enrico Bentivegna, Michelangelo Luciani, et al.Advances in Therapy|November 9, 2023
Unmet Needs in the Acute Treatment of MigraineEnrico Bentivegna, Silvia Galastri, Dilara Onan, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|May 16, 2022
Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with MigraineFidel Dominique Festin Ambat, Enrico Bentivegna, Paolo MartellettiPain and Therapy|February 17, 2021
Structural and Functional Brain Changes in MigraineSait Ashina, Enrico Bentivegna, Paolo Martelletti, et al.Expert Review of Neurotherapeutics|December 10, 2020
Evaluating and managing severe headache in the emergency departmentMichelangelo Luciani, Andrea Negro, Valerio Spuntarelli, et al.Expert Opinion on Biological Therapy|May 19, 2021
Eptinezumab for the treatment of migraineValerio Spuntarelli, Andrea Negro, Michelangelo Luciani, et al.Expert Review of Neurotherapeutics|February 23, 2022
Tele-healthcare in migraine medicine: from diagnosis to monitoring treatment outcomesEnrico Bentivegna, Cristina Tassorelli, Roberto De Icco, et al.International Journal of Environmental Research and Public Health|January 27, 2021
Reduction of Multidrug-Resistant (MDR) Bacterial Infections during the COVID-19 Pandemic: A Retrospective StudyEnrico Bentivegna, Michelangelo Luciani, Luca Arcari, et al.Pageof 34